Human respiratory syncytial virus (RSV) is the primary cause of respiratory infection in infants worldwide. Currently there is no available vaccine, although studies in animal models have demonstrated protective immunity induced by an epitope of the RSV G-protein representing amino acids 174-187. Two peptides containing amino acids 174-187 of the G-protein of the human RSV A2 strain (NF1-RSV/172-187 and NF2-RSV/170-191) were separately engineered as translational fusions with the alfalfa mosaic virus coat protein and individually expressed in Nicotiana tabacum cv. Samsun NN plants through virus infection. RSV G-protein peptides were expressed in infected plant tissues at significant levels within 2 wk of inoculation and purified as part of recombinant alfalfa mosaic virions. BALB/c mice immunized intraperitoneally with three doses of the purified recombinant viruses showed high levels of serum antibody specific for RSV G-protein and were protected against infection with RSV Long strain.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1096/fj.00-0144com | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Structure switching aptamer enhance sensitivity and specificity of photonic crystal-based sensors for RSV-G protein detection.
Biosens Bioelectron
January 2025
Beijing Institute of Technology School of Chemistry and Chemical Engineering, China. Electronic address:
Photonic crystal-based aptasensors for viral proteins detection offer the advantage of producing visible readouts. However, they usually suffer from limited sensitivity and high non-specific background noise. A significant contributing factor to these issues is the use of fixed-conformation aptamers in these sensors.
View Article and Find Full Text PDFSpirochrains A-D, Four Caged [5,6,5] Spirocyclic Amides from an Antarctic Fungus SCSIO 05702 with Anti-RSV Activities.
Org Lett
January 2025
CAS Key Laboratory of Tropical Marine Bio-resources and Ecology/Guangdong Key Laboratory of Marine Materia Medica, South China Sea Institute of Oceanology, Chinese Academy of Sciences, Guangzhou 510301, China.
Spirochrains A-D, four undescribed spirocyclic amides, were obtained from an Antarctic fungus, SCSIO 05702. Their structures were elucidated through spectroscopic analysis and quantum calculations. Spirochrains A-D possess a rarely reported cage-like 5/6/5 fused spirocyclic amide scaffold.
View Article and Find Full Text PDFEvaluation of Immunoglobulin A Enzyme Immunoassays to Detect Primary Respiratory Syncytial Virus Infection in Infants and Young Children.
J Infect Dis
November 2024
Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine.
Background: Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections in children <2 years of age. Prior infection in a child is usually determined by RSV antibodies; however, in young children, persisting maternal immunoglobulin G antibodies can incorrectly indicate past RSV infection. We developed and evaluated 4 immunoglobulin A (IgA) antibody enzyme immunoassays (EIAs) with the RSV F, subgroup G (Ga or Gb proteins) or RSV lysate antigens to distinguish infection induced from persisting maternal RSV antibodies.
View Article and Find Full Text PDFPrevention of respiratory syncytial virus from 1991 to 2024: a systematic review and bibliometrics analysis.
Transl Pediatr
October 2024
Department of Paediatrics, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Article Synopsis
- RSV poses serious health and financial risks to children and the elderly, with prevention being the most effective strategy since there is no specific treatment available.
- A bibliometric analysis of research on RSV prevention from January 1991 to August 2024 was conducted using various data analysis tools, revealing significant trends and key contributors in the field.
- Key findings showed that the U.S., England, and the Netherlands are leading in research output, with important proteins targeted for drug development, and advancements in vaccines and monoclonal antibodies making promising progress in clinical research.
Both chebulagic acid and punicalagin inhibit respiratory syncytial virus entry via multi-targeting glycoprotein and fusion protein.
J Virol
December 2024
Jiangsu Key Laboratory of Children's Health and Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections, with no currently available small-molecule drugs that are both safe and effective. A major obstacle in antiviral drug development is the rapid emergence of drug-resistant viral strains. Targeting multiple viral compounds may help mitigate the development of resistance.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!